Literature DB >> 17466307

Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids.

Xinyan Liu1, Takashi Ukai2, Hiromichi Yumoto3, Michael Davey4, Sulip Goswami1, Frank C Gibson1, Caroline A Genco5.   

Abstract

OBJECTIVE: Toll-like receptors (TLRs), a group of pathogen-associated microbial pattern recognition receptors, play an important role in innate immune signaling and are differentially regulated in chronic inflammatory diseases such as atherosclerosis. However, the involvement of TLRs in the progression of atherosclerosis is still unclear. METHODS AND
RESULTS: TLR2 and apolipoprotein E double knockout (Tlr2(-/-)Apoe(-/-)) mice were generated and the progressive formation of atherosclerotic plaque in the aortas was examined in mice fed a normal chow diet. We demonstrate that inactivation of TLR2 resulted in reduced progression of atherosclerosis in both male and female Apoe(-/-) mice. Likewise, TLR2 deficiency resulted in a reduction in lipid accumulation and decreased macrophage recruitment to the aortic sinus, as well as reduced monocyte chemoattractant protein-1 (MCP-1) levels. Furthermore, macrophages isolated from Tlr2(-/-)Apoe(-/-) mice demonstrated significantly reduced MCP-1 production upon stimulation with a TLR2 ligand. However, no differences in acetylated low-density lipoprotein uptake and foam cell formation were observed in macrophages isolated from Tlr2(-/-)Apoe(-/-) mice as compared to Apoe(-/-) mice.
CONCLUSIONS: TLR2 plays a critical role in the progression of atherosclerosis in Apoe(-/-) mice, which is independent of dietary lipids and macrophage lipid uptake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466307      PMCID: PMC2243224          DOI: 10.1016/j.atherosclerosis.2007.03.025

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  37 in total

1.  Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.

Authors:  Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

2.  DisSARMing Toll-like receptor signaling.

Authors:  Luke A J O'Neill
Journal:  Nat Immunol       Date:  2006-10       Impact factor: 25.606

3.  Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.

Authors:  R K Tangirala; E M Rubin; W Palinski
Journal:  J Lipid Res       Date:  1995-11       Impact factor: 5.922

4.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

Authors:  S Ylä-Herttuala; B A Lipton; M E Rosenfeld; T Särkioja; T Yoshimura; E J Leonard; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 5.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

6.  Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.

Authors:  X Zhou; G Paulsson; S Stemme; G K Hansson
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

Review 7.  Chemokines in the pathogenesis of vascular disease.

Authors:  Israel F Charo; Mark B Taubman
Journal:  Circ Res       Date:  2004-10-29       Impact factor: 17.367

8.  Monocyte chemoattractant protein-1 in human atheromatous plaques.

Authors:  N A Nelken; S R Coughlin; D Gordon; J N Wilcox
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

9.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

Authors:  A S Plump; J D Smith; T Hayek; K Aalto-Setälä; A Walsh; J G Verstuyft; E M Rubin; J L Breslow
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

10.  Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.

Authors:  Kristina Skålén; Maria Gustafsson; Ellen Knutsen Rydberg; Lillemor Mattsson Hultén; Olov Wiklund; Thomas L Innerarity; Jan Borén
Journal:  Nature       Date:  2002-06-13       Impact factor: 49.962

View more
  59 in total

Review 1.  Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.

Authors:  Ling Zhao; Joo Y Lee; Daniel H Hwang
Journal:  Nutr Rev       Date:  2011-06       Impact factor: 7.110

Review 2.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

3.  Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses.

Authors:  Chie Hayashi; Andres G Madrigal; Xinyan Liu; Takashi Ukai; Sulip Goswami; Cynthia V Gudino; Frank C Gibson; Caroline A Genco
Journal:  J Innate Immun       Date:  2010-05-10       Impact factor: 7.349

Review 4.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

5.  Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress.

Authors:  Tracie A Seimon; Marissa J Nadolski; Xianghai Liao; Jorge Magallon; Matthew Nguyen; Nicole T Feric; Marlys L Koschinsky; Richard Harkewicz; Joseph L Witztum; Sotirios Tsimikas; Douglas Golenbock; Kathryn J Moore; Ira Tabas
Journal:  Cell Metab       Date:  2010-11-03       Impact factor: 27.287

6.  The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications.

Authors:  Ishwarlal Jialal; Harmeet Kaur
Journal:  Curr Diab Rep       Date:  2012-02-08       Impact factor: 4.810

7.  Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy.

Authors:  Harmeet Kaur; Alexander Chien; Ishwarlal Jialal
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

8.  Suppression of Tie-1 in endothelial cells in vitro induces a change in the genome-wide expression profile reflecting an inflammatory function.

Authors:  Barden Chan; Vikas P Sukhatme
Journal:  FEBS Lett       Date:  2009-02-21       Impact factor: 4.124

Review 9.  Emerging role of Toll-like receptors in atherosclerosis.

Authors:  Linda K Curtiss; Peter S Tobias
Journal:  J Lipid Res       Date:  2008-11-01       Impact factor: 5.922

10.  Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.

Authors:  Mohan R Dasu; Sridevi Devaraj; Samuel Park; Ishwarlal Jialal
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.